Nebulised interferon-β1a (SNG001) in hospitalised COVID-19: SPRINTER phase III study

BACKGROUND: Despite the availability of vaccines and therapies, patients are being hospitalised with coronavirus disease 2019 (COVID-19). Interferon (IFN)-β is a naturally occurring protein that stimulates host immune responses against most viruses, including severe acute respiratory syndrome corona...

Descripción completa

Detalles Bibliográficos
Autores principales: Monk, Phillip D., Brookes, Jody L., Tear, Victoria J., Batten, Toby N., Mankowski, Marcin, Adzic-Vukicevic, Tatjana, Crooks, Michael G., Dosanjh, Davinder P.S., Kraft, Monica, Brightling, Christopher E., Gabbay, Felicity J., Holgate, Stephen T., Djukanovic, Ratko, Wilkinson, Tom M.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2023
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790107/
https://www.ncbi.nlm.nih.gov/pubmed/36994453
http://dx.doi.org/10.1183/23120541.00605-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790107/
https://www.ncbi.nlm.nih.gov/pubmed/36994453
http://dx.doi.org/10.1183/23120541.00605-2022

Ejemplares similares